Literature DB >> 19042129

Calculation of binding free energies for non-zinc chelating pyrimidine dicarboxamide inhibitors with MMP-13.

Noel Carrascal1, Robert C Rizzo.   

Abstract

All-atom molecular dynamics (MD) simulations in both explicit and implicit solvent, followed by MM-GBSA energy analysis, have been used to estimate binding free energies of four pyrimidine dicarboxamide inhibitors with human collagenase-3 (MMP-13) for comparison with experimental activities. Energetic analysis reveals that affinity is driven primarily by favorable van der Waals interactions and burial of total surface area. The computed effects of desolvation, as a function of ligand structure, quantitatively show that hydrophilic derivatives pay greater penalties upon binding than their related more hydrophobic analogs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19042129      PMCID: PMC2646414          DOI: 10.1016/j.bmcl.2008.11.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models.

Authors:  P A Kollman; I Massova; C Reyes; B Kuhn; S Huo; L Chong; M Lee; T Lee; Y Duan; W Wang; O Donini; P Cieplak; J Srinivasan; D A Case; T E Cheatham
Journal:  Acc Chem Res       Date:  2000-12       Impact factor: 22.384

2.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

3.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

4.  Zinc binding in proteins and solution: a simple but accurate nonbonded representation.

Authors:  R H Stote; M Karplus
Journal:  Proteins       Date:  1995-09

5.  Structural basis for the highly selective inhibition of MMP-13.

Authors:  Christian K Engel; Bernard Pirard; Sandra Schimanski; Reinhard Kirsch; Jörg Habermann; Otmar Klingler; Volkhard Schlotte; Klaus Ulrich Weithmann; K Ulrich Wendt
Journal:  Chem Biol       Date:  2005-02

Review 6.  Matrix metalloproteinase inhibitors and cancer: trials and tribulations.

Authors:  Lisa M Coussens; Barbara Fingleton; Lynn M Matrisian
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

7.  Binding of antifusion peptides with HIVgp41 from molecular dynamics simulations: quantitative correlation with experiment.

Authors:  Bentley Strockbine; Robert C Rizzo
Journal:  Proteins       Date:  2007-05-15

Review 8.  Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.

Authors:  Maria Pavlaki; Stanley Zucker
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

9.  A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized born molecular dynamics simulations.

Authors:  Robert C Rizzo; Samuel Toba; Irwin D Kuntz
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

  9 in total
  2 in total

1.  Origins of resistance to the HIVgp41 viral entry inhibitor T20.

Authors:  Brian E McGillick; Trent E Balius; Sudipto Mukherjee; Robert C Rizzo
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

2.  Quantitative prediction of fold resistance for inhibitors of EGFR.

Authors:  Trent E Balius; Robert C Rizzo
Journal:  Biochemistry       Date:  2009-09-08       Impact factor: 3.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.